


BioMARC Email Formats
Pharmaceutical Manufacturing • Fort Collins, Colorado, United States • 21-50 Employees
BioMARC Email Formats
BioMARC uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@colostate.edu), used 57.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@colostate.edu | 57.9% |
{first initial} | j@colostate.edu | 21.1% |
{first initial}.{last name} | j.doe@colostate.edu | 10.5% |
{first name}{last name} | johndoe@colostate.edu | 10.5% |
Key Contacts at BioMARC
Jordan Flatt
Associate Director Of Manufacturing Operations
Bio Marc
Director
Company overview
| Headquarters | 3185 Rampart Road, Fort Collins, Colorado 80523, US |
| Phone number | +19704924385 |
| Website | |
| NAICS | 3254 |
| Keywords | Vaccines, Diagnostic Products, Bsl-3, Vaccine Development, Process Development Services, Bsl-2 Containment, Established Master And Working Cell Banks, Manufacturing And Testing Services, Select Agent Bio Security Conditions, Spore Former Containment, Testing And Manufacturing Of Therapeutic |
| Founded | 2006 |
| Employees | 21-50 |
| Socials |
About BioMARC
BioMARC (Biopharmaceutical Manufacturing & Academic Resource Center) is a nonprofit Contract Manufacturing Organization (CMO) owned and operated by Colorado State University (CSU). BioMARC was created to translate and produce biopharmaceutical products for non-clinical, clinical, and commercial use under Biosafety Level 3 (BSL-3) and BSL-2 containment (including spore former containment) and Select Agent (SA) biosecurity conditions. In addition to manufacturing and testing services, BioMARC offers product and process development services, which includes the creation of development programs focused on implementation of cGMP regulations and scalability issues. BioMARC has extensive expertise in developing and optimizing product manufacturing processes and related tests. To-date, BioMARC has brought a diagnostic parenteral product through clinical trial and commercial production, manufactured a virus vaccine for a phase I clinical study, established several master and working cell banks, developed and qualified cell based and analytical assays for product testing and release, and established a controlled process for manufacturing a therapeutic product for preclinical studies. MISSION: To serve CSU’s needs in research, service, and the translation of new discoveries into products to impact the world at large. BioMARC will leverage the renowned CSU research expertise within the Infectious Disease Research Center and the greater CSU community, together with strategic partnerships to accelerate the development, manufacturing and commercialization of biologic products, from the bench to the bedside. BioMARC will implement the highest quality and regulatory standards in all phases of product development and cGMP manufacturing processes, including preclinical, clinical (Phase I-III) and commercial level manufacturing to accomplish this mission well aligned to CSU’s objectives in public service, economic development, and positive global impact.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
BioMARC has 18 employees across 4 departments.
Departments
Number of employees
Funding Data
BioMARC has never raised funding before.
Frequently asked questions
4.8
40,000 users



